Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

Clinical trial NCT07150845 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07150845
Sponsor: Evommune, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atoptic Dermatitis

Start date: 2025-08-26
Primary completion: 2026-07-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.